Successful treatment of anti-PTX3 positive seronegative rheumatoid arthritis with upadacitinib.

Haojie XuBang SuRong LiLu WangJiaxin ZhouLidan Zhao

Published in: International journal of rheumatic diseases (2023)

Seronegative rheumatoid arthritis (SNRA) can be a rapid-progressing and highly disabling disease. Anti-PTX3 autoantibody may be a potential biomarker in SNRA diagnosis. SNRA patients could respond well to upadacitinib.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
newly diagnosed
interstitial lung disease
peritoneal dialysis
ankylosing spondylitis
loop mediated isothermal amplification